Predictors of axillary node response in clinically node-positive patients undergoing neoadjuvant chemotherapy for breast cancer

被引:0
|
作者
Ladak, Farah [1 ]
Lesniak, David [1 ]
Chua, Natalie [1 ]
Peiris, Lashan [1 ]
机构
[1] Univ Alberta, Edmonton, AB, Canada
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
581556
引用
收藏
页码:264 / 265
页数:2
相关论文
共 50 条
  • [41] Early Outcomes of Node-Positive Breast Cancer Patients Treated with Targeted Axillary Node Dissection after Neoadjuvant Chemotherapy
    Sun, James
    Carr, Michael
    Sun, Weihong
    Zhou, Junmin
    Kim, Youngchul
    Hoover, Susan J.
    Kiluk, John V.
    Lee, Marie Catherine
    Laronga, Christine
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2020, 231 (04) : S267 - S267
  • [42] ASO Author Reflections: Low Rates of Axillary Recurrence in Clinically Node-Positive Breast Cancer Patients Undergoing Sentinel Lymph Node Biopsy Alone Following Pathologic Response to Neoadjuvant Chemotherapy
    Wong, Stephanie M.
    Boileau, Jean Francois
    ANNALS OF SURGICAL ONCOLOGY, 2021, 28 (05) : 2630 - 2631
  • [43] THE VALUE OF NEOADJUVANT CHEMOTHERAPY IN CLINICALLY NODE-POSITIVE BLADDER CANCER
    Werntz, Ryan
    Smith, Zach
    Packiam, Vignesh
    Riedinger, Chris
    Fantus, Jake
    Smith, Norm
    Steinberg, Gary
    JOURNAL OF UROLOGY, 2018, 199 (04): : E314 - E315
  • [44] Implementation of sentinel lymph node biopsy following neoadjuvant chemotherapy in clinically node-positive breast cancer
    Mele, Alessandra
    Alapati, Amulya
    Serres, Stephanie
    James, Ted
    ANNALS OF SURGICAL ONCOLOGY, 2019, 26 : 288 - 288
  • [45] Nomogram predicting Axillary PCR after neoadjuvant chemotherapy in node-positive breast cancer
    Kim, J. Y.
    Kim, S.
    Ryu, J.
    Park, H. S.
    Park, S.
    Kim, S. I.
    BREAST, 2015, 24 : S138 - S138
  • [46] Omission of axillary dissection after neoadjuvant chemotherapy for node-positive primary breast cancer
    Matsumoto, A.
    Yasuko, U.
    Tsukahara, D.
    Jinno, H.
    EUROPEAN JOURNAL OF CANCER, 2020, 138 : S29 - S29
  • [47] Evaluation of axillary response to neoadjuvant systemic therapy with sentinel node biopsy and axillary wire in node-positive breast cancer
    Navarro Sierra, Javier
    Rubio Cuesta, Patricia
    Villalobos Salguero, Francisco Javier
    Espiau Romera, Andrea
    Garcia Mur, Maria del Carmen
    Vicente Gomez, Isabel
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2021, 42 (06) : 1291 - 1299
  • [48] Validity of omission of axillary lymph node dissection after neoadjuvant chemotherapy for node-positive primary breast cancer
    Matsumoto, Akiko
    Umemoto, Yasuko
    Tsukahara, Daisuke
    Jinno, Hiromitsu
    CANCER RESEARCH, 2020, 80 (04)
  • [49] Nomogram Predicting Axillary Lymph Node Dissection Omission After Neoadjuvant Chemotherapy for Node-positive Breast Cancer
    Seki, Hirohito
    Ishiguro, Yuki
    Makino, Akitsugu
    Yamaguchi, Kei
    Imoto, Shigeru
    ANTICANCER RESEARCH, 2024, 44 (11) : 5131 - 5138
  • [50] Factors Associated with Axillary Lymph Node Status in Clinically Node-Negative Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy
    Yu, Chi-Chang
    Cheung, Yun-Chung
    Ueng, Shir-Hwa
    Lin, Yung-Chang
    Kuo, Wen-Ling
    Shen, Shih-Che
    Lo, Yung-Feng
    Chen, Shin-Cheh
    CANCERS, 2022, 14 (18)